Device Energy

Enseal X1

Payments companies reported to CMS as associated with Enseal X1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$475Kassociated payments (2023-2025)

1,092clinicians with associated payments

5companies reporting

By year

2023 $216K

2024 $182K

2025 $77K

Payments reported as associated with Enseal X1, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $178K

Obstetrics & Gynecology $77K

Colon & Rectal Surgery $64K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $56K

Gynecology $15K

Orthopaedic Trauma $15K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Enseal X1

These are the largest totals companies reported as associated with Enseal X1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Farah Husain	Portland, OR	Surgery	$62,208.79
Kurian Thott	Stafford, VA	Obstetrics & Gynecology	$43,536.59
Bob Kiaii	Sacramento, CA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$38,202.76
Isaac Felemovicius	Maple Grove, MN	Colon & Rectal Surgery	$34,201.10
Alan Wittgrove	Del Mar, CA	Surgery	$29,441.56
Brian Binetti	Rhinebeck, NY	Surgery	$26,408.84
Mireille Truong	West Hollywood, CA	Obstetrics & Gynecology	$22,524.00
Jean Ashburn	Cleveland, OH	Colon & Rectal Surgery	$22,386.11
Santiago Horgan	San Diego, CA	Surgery	$21,600.00
Kourosh Asgarian	Neptune, NJ	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$15,937.50

Prescribed Enseal X1?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.